Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Transenterix Inc (TRXC)

Transenterix Inc (TRXC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Transenterix Inc 635 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560 USA

www.transenterix.com P: 919-765-8400

Description:

TransEnterix Inc. designs, develops and manufactures medical-devices. It offers SPIDER(R) Surgical System, a laparoscopic surgical platform that allows intra-abdominal triangulation procedures to be performed with articulating instruments through a single site. The company is primarily focused on the development and commercialization of SurgiBot, a patient-side minimally invasive surgical robotic system. TransEnterix Inc., formerly known as SafeStitch Medical, Inc., is based in United States.

Key Statistics

Overview:

Market Capitalization, $K 648,208
Shares Outstanding, K 142,777
Annual Sales, $ 8,530 K
Annual Net Income, $ -154,200 K
Last Quarter Sales, $ 810 K
Last Quarter Net Income, $ -15,080 K
60-Month Beta 1.95
% of Insider Shareholders 3.10%
% of Institutional Shareholders 6.40%
Float, K 138,351
% Float 96.90%

Growth:

1-Year Return 257.89%
3-Year Return -81.96%
5-Year Return -92.44%
5-Year Revenue Growth 2,032.50%
5-Year Earnings Growth 49.28%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 03/11/21
Earnings Per Share ttm -1.57
EPS Growth vs. Prev Qtr 42.86%
EPS Growth vs. Prev Year 89.75%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-13 on 12/12/19

TRXC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -83.74%
Return-on-Assets % -64.94%
Profit Margin % -1,807.74%
Debt/Equity 0.04
Price/Sales 67.21
Price/Cash Flow 3.29
Price/Book 6.55
Book Value/Share 0.62
Interest Coverage -33.13
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar